Active	Status	Sponsor type	Region	Phase	Filter
2 Active 13 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Maas, Corey
BLESSI, NCT02819063 / 2015-002164-16: Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I (BLESS I)	Recruiting	3	40	US	BoNT/A-DP, Sterile, 0.9% Sodium chloride injection	The Maas Clinic, Croma-Pharma GmbH	Glabellar Rhytids	12/17
Bass, Rachel
BLESSI, NCT02819063 / 2015-002164-16: Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I (BLESS I)	Recruiting	3	40	US	BoNT/A-DP, Sterile, 0.9% Sodium chloride injection	The Maas Clinic, Croma-Pharma GmbH	Glabellar Rhytids	12/17
Fuller, Kristin
No trials found
Shamban, Emily
No trials found
Mass, Corey
No trials found